Cargando…
Research models and mesenchymal/epithelial plasticity of osteosarcoma
Most osteosarcomas (OSs) develop from mesenchymal cells at the bone with abnormal growth in young patients. OS has an annual incidence of 3.4 per million people and a 60–70% 5-year surviving rate. About 20% of OS patients have metastasis at diagnosis, and only 27% of patients with metastatic OS surv...
Autores principales: | Yu, Xiaobin, Yustein, Jason T., Xu, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141200/ https://www.ncbi.nlm.nih.gov/pubmed/34022967 http://dx.doi.org/10.1186/s13578-021-00600-w |
Ejemplares similares
-
Recent Insights into Therapy Resistance in Osteosarcoma
por: Prudowsky, Zachary D., et al.
Publicado: (2020) -
Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
por: Nirala, Bikesh K., et al.
Publicado: (2023) -
Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
por: Hinton, Kristin, et al.
Publicado: (2023) -
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
por: Nirala, Bikesh K., et al.
Publicado: (2023) -
Epithelial–mesenchymal plasticity in carcinoma metastasis
por: Tsai, Jeff H., et al.
Publicado: (2013)